Healthsouth Corp (HLS) 40.54 $HLS 7 Medical Stocks to

New Post Public Reply Private Reply Replies (0) Message Board

Jun 12, 2016 at 11:11 PM

Healthsouth Corp (HLS) 40.54 $HLS

7 Medical Stocks to Buy with Market-Beating Yields
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 8:50AM CDT
Medical is one of the very few sectors that generally show great resilience during volatile phases in the market.
KND: 11.52 (-0.61), ABT: 38.40 (-0.47), JNJ: 117.01 (+0.01), PFE: 35.29 (-0.02), BMY: 72.65 (-0.08), HLS: 40.54 (-1.02), DRAD: 5.49 (+0.02)

Chemed Posts Balanced Growth amid Coding Change Issues
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 5:42AM CDT
On Jun 7, 2016, we issued an updated research report on Chemed Corporation (CHE).
CHE: 132.09 (-1.78), PMC: 26.43 (-0.66), LHCG: 42.75 (-0.78), HLS: 40.54 (-1.02)

AmSurg (AMSG): Strong Q1 on Organic & Acquisition Growth
Zacks Equity Research - Zacks Investment Research - Thu May 26, 6:19AM CDT
On May 20, 2016, we issued an updated research report on Nashville, TN-based AmSurg Corp. (AMSG).
AMSG: 80.11 (-0.89), USPH: 59.40 (-0.25), LHCG: 42.75 (-0.78), HLS: 40.54 (-1.02)

HEALTHSOUTH (HLS): Strong Industry, Solid Earnings Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Wed May 25, 7:45AM CDT
HEALTHSOUTH (HLS) in the Medical-Outpatient/Home Care space is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.
HLS: 40.54 (-1.02)

DaVita to Expand in Orlando with Family Health Care Buyout
Zacks Equity Research - Zacks Investment Research - Mon May 23, 3:07PM CDT
DaVita Healthcare Partners (DVA) has entered into a definitive agreement to acquire Family Health Care of Central Florida to expand its presence in Orlando metro area.
PMC: 26.43 (-0.66), AFAM: 42.11 (-0.81), DVA: 76.08 (-1.13), HLS: 40.54 (-1.02)

Moving Average Crossover Alert: HEALTHSOUTH (HLS)
Zacks Equity Research - Zacks Investment Research - Mon May 23, 8:42AM CDT
HEALTHSOUTH Corp. (HLS) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
HLS: 40.54 (-1.02)

Quest Diagnostics (DGX) Divests Focus, Cuts Sales View
Zacks Equity Research - Zacks Investment Research - Thu May 19, 5:44AM CDT
Quest Diagnostics Inc. (DGX) has updated its outlook for 2016 following the completion of the sale of Focus Diagnostics Inc.
AFAM: 42.11 (-0.81), LHCG: 42.75 (-0.78), DGX: 77.45 (-1.30), HLS: 40.54 (-1.02)

4 GARP Stocks to Boost Your Portfolio Returns
Zacks Equity Research - Zacks Investment Research - Thu May 12, 11:31AM CDT
Investors following GARP would love to invest in undervalued stocks that offer solid growth prospects too.
TJX: 76.97 (-0.34), CASY: 119.63 (+0.31), HLS: 40.54 (-1.02), SIG: 89.13 (-0.47)

HealthSouth To Participate In The UBS Global Healthcare Conference
PR Newswire - Tue May 10, 3:30PM CDT
HealthSouth Corporation (NYSE: HLS) today announced it will participate in the UBS Global Healthcare Conference in New York City, May 23-25, 2016.
HLS: 40.54 (-1.02)

The Kroger Co trade offers a 10% return in 256 days, or find similar option trades on NXP Semiconductors, Sotheby's, HEALTHSOUTH Corp., and Mylan
PR Newswire - Tue May 10, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for KR, NXPI, BID, HLS and MYL.
BID: 31.86 (-0.13), KR: 36.81 (+0.23), MYL: 44.53 (-1.23), NXPI: 88.43 (-1.86), HLS: 40.54 (-1.02)

The Zacks Analyst Blog Highlights: Vectrus, PRGX Global, Nobilis Health, HEALTHSOUTH and Raymond James Financial
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:30AM CDT
The Zacks Analyst Blog Highlights: Vectrus, PRGX Global, Nobilis Health, HEALTHSOUTH and Raymond James Financial
VEC: 26.23 (+0.38), HLTH: 2.61 (-0.09), RJF: 52.86 (-1.37), PRGX: 5.63 (-0.03), HLS: 40.54 (-1.02)

BioScrip (BIOS) Q1 Loss Wider than Expected, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Tue May 10, 8:11AM CDT
BioScrip, Inc. (BIOS) reported net loss from continuing operations of 17 cents per share in the first quarter of 2016.
USPH: 59.40 (-0.25), AFAM: 42.11 (-0.81), BIOS: 2.83 (-0.10), HLS: 40.54 (-1.02)

5 Stocks to Buy on Service Sector Strength
Swarup Gupta - Zacks Investment Research - Mon May 09, 9:23AM CDT
Nearly all the employment gains for April came in from three services sectors.
VEC: 26.23 (+0.38), HLTH: 2.61 (-0.09), RJF: 52.86 (-1.37), PRGX: 5.63 (-0.03), HLS: 40.54 (-1.02)

Amedisys (AMED) Lags Q1 Earnings, Revenues Top the Mark
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:56AM CDT
Amedisys Inc. (AMED) reported adjusted earnings from continuing operations of 33 cents per share in the first quarter of 2016.
BSX: 23.02 (-0.30), AFAM: 42.11 (-0.81), AMED: 51.80 (-1.00), HLS: 40.54 (-1.02)

HealthSouth Declares Dividend on Common Stock
PR Newswire - Thu May 05, 3:30PM CDT
HealthSouth Corporation (NYSE: HLS) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.23 per share, payable on July 15, 2016, to holders of record on July 1, 2016.
HLS: 40.54 (-1.02)

Chemed (CHE) Q1 Earnings Miss the Mark, Revenues in Line
Zacks Equity Research - Zacks Investment Research - Mon May 02, 9:53AM CDT
Chemed Corp. (CHE) reported first-quarter 2016 adjusted earnings per share (EPS) of $1.53.
CHE: 132.09 (-1.78), AFAM: 42.11 (-0.81), AMED: 51.80 (-1.00), HLS: 40.54 (-1.02)

Can The Uptrend Continue for with HEALTHSOUTH (HLS)?
Zacks Equity Research - Zacks Investment Research - Mon May 02, 8:23AM CDT
Investors certainly have to be happy with HEALTHSOUTH Corp. (HLS) and its short term performance.
HLS: 40.54 (-1.02)

HealthSouth Reports Strong Revenue, Volume, and Adjusted EBITDA Growth in Both Segments for First Quarter 2016 and Raises Full-Year 2016 Guidance
PR Newswire - Tue Apr 26, 3:30PM CDT
HealthSouth Corporation (NYSE: HLS), one of the nation's largest providers of post-acute healthcare services, offering both facility-based and home-based post-acute services, today reported its results of operations for the first quarter ended March 31, 2016.
HLS: 40.54 (-1.02)

Post Acute Medical acquires HealthSouth Rehabilitation Hospital of Beaumont
PR Newswire - Tue Apr 26, 8:28AM CDT
Post Acute Medical, LLC, (PAM) recently announced that it will acquire HealthSouth Rehabilitation Hospital of Beaumont, 3340 Plaza 10 Boulevard, Beaumont, Texas, from HealthSouth.
HLS: 40.54 (-1.02)

HealthSouth to Hold Annual Stockholder Meeting
PR Newswire - Mon Apr 11, 9:45AM CDT
HealthSouth Corporation (NYSE: HLS) will hold its annual meeting of stockholders at 11 a.m. CT, on Thursday, May 5, 2016, at its corporate headquarters, 3660 Grandview Parkway in Birmingham, Alabama.
HLS: 40.54 (-1.02)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quantum Space Joins $185M NASA Lunar Transport Deal

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

ecozy's Brezzano Switch: Brewing Simplicity at Home

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Evaluating GLP-1 Telehealth? Key Questions to Consider

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Aurora Innovation Faces Legal Heat Amid Delays

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Adding Fireplaces: Home Comfort or Construction Headache?

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

2027 Toy of the Year Finalists Energize Play Market

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Boston STEM Expo Sparks Young Minds in Engineering

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

FuelCell Faces Class Action Crunch as Deadline Looms

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Johnson & Johnson Unveils Promising PsA Treatment Data

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Off-Broadway Play 'DUST' Raises Autism Support Funds

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...